Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Int J Obes 37(9):11611168 Holst JJ (2019) From the incretin concept and the discovery of GLP-1 to todays diabetes therapy
The complaint alleges that, in reality, defendants understated the ongoing impact of the personalization exception to the compounded GLP-1 exclusion, overstated the likelihood that patients would switch to Novo's branded alternatives, and overstated the GLP-1 market's expansion or Novo's ability to penetrate it to achieve continued growth
How it works in the real world could be different, says Dr
Singh KK, Mridula D, Rehal J, et al
Liver-on-a-chip integrated with label-free optical biosensors for rapid and continuous monitoring of drug-induced toxicity
US$ 25.07
US$ 21.84
US$ 21.61
US$ 28.94
US$ 20.12
US$ 24.13
US$ 24.56
US$ 25.09
US$ 23.89
US$ 26.05
US$ 29.60
US$ 25.08
